Due to the recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the homepage of the official account to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing OverviewAI Medical Record Solution Provider Abridge Completes $30 Million Series B FinancingOn October 26, Abridge, a provider of AI medical record solutions, announced the completion of a $30 million Series B financing round. This round was led by Spark Capital, with participation from Bessemer Venture Partners, CVS Health Ventures, Mayo Clinic, and others. The investment will support large-scale healthcare system expansion, accelerate product advancements, and create more value for patients, clinicians, and healthcare systems.Neuros Medical, a developer of neurostimulation therapies, raises $25 million in financingOn October 31, Neuros Medical, a developer of neurostimulation therapies, secured $25 million in financing, with this round led by Trinity Capital. The company plans to use the funds to increase recently raised equity and further expand its business scale to support its commercialization progress.Clinical Data Processing System Provider Betteromics Completes $20 Million Series A FinancingOn October 26, clinical data processing system provider Betteromics completed a $20 million Series A financing round, led by Sofinnova Partners and Triatomic Capital, with participation from SHAKTI. The company plans to use the funds to expand its team and broaden its marketing and sales efforts targeting life sciences companies, ranging from startups to large enterprises.Huichuang Medical, a developer of brain function imaging products, completes over 100 million yuan in B-round financingOn October 31, Huichuang Medical, a developer of brain function imaging products, completed a B-round financing of over 100 million yuan, led by Zhongke Haichuang, with participation from Yida Capital, existing shareholder Qingyuan Investment, and Daoyuan Capital. This round of financing will mainly be used to further promote the construction of the company’s near-infrared (fNIRS) brain function imaging product as the leading brand in China, as well as clinical trials for transcranial light modulation therapy for degenerative diseases. Changhai Capital continues to serve as the exclusive financial advisor for the company's financing.Leadinno Medical Valley, a developer of medical devices and consumables in the field of pain and neuromodulation, has completed an A+ round of financing exceeding 100 million yuan.On October 25, Leadinno Medical Valley, a developer of medical devices and consumables in the field of pain management and neuromodulation, completed an over RMB100-million Series A+ round of financing. This round of financing was led by Fortune Venture Capital, with Wuxi Zhaofeng Lifu participating, and SourceOne Capital serving as the exclusive financial advisor. The funds raised will be used for the research, development, and production of spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) products, as well as for company operations.Continuous Glucose Monitoring Technology Developer Sugar.fit Secures $11 Million in Series A FundingOn October 31, continuous blood glucose monitoring technology developer Sugar.fit secured $11 million in Series A funding, led by MassMutual Ventures, with participation from Cure.fit, Tanglin Venture Partners, and Endiya Partners. The funds will be used for market promotion and new product development.Medical Data Exchange Platform Rymedi Raises $9 Million in Series A FundingOn October 25, medical data exchange platform Rymedi secured $9 million in Series A funding. This round was co-led by RW3 Ventures and White Star Capital, with participation from Blockchange Ventures, Avalanche’s Blizzard Fund, and several angel investors. The company plans to use the funds to expand the platform's reach.Non-invasive brain-computer interface system developer MicroLink Medical completes multi-million yuan angel round financingOn November 1, Weiling Medical, a developer of non-invasive brain-computer interface systems, completed an angel round of financing worth tens of millions of yuan. The round was led by Gaorong Capital, with participation from Leadinno Medical Valley Venture Capital Fund and Qiji Investment, and follow-up investment from existing shareholder CDH Investments. The funds will mainly be used to advance the research and development of a fully implantable medical-grade brain-computer interface system.Health Monitoring System Developer Neteera Completes Approximately $6.7 Million Series B FinancingOn October 31, Neteera, a developer of health monitoring systems, completed a $6.7 million Series B financing round led by Aescuvest. The funds will be used to accelerate production to meet the growing demand for the Neteera platform, recruit more installation and deployment personnel, and further solidify its leading position in the non-contact patient monitoring market.AI Personalized Gut Health Company Jona Raises $5 Million in FinancingOn November 1, Jona, an AI personalized gut health company, raised $5 million in funding led by Breyer Capital and Meridian Street Capital. The company plans to use the funds to promote its products and enable more consumers to use its at-home microbiome analysis kits.BRAINBox, a Developer of Brain Injury Diagnosis and Prognosis Systems, Completes Series B FinancingOn October 30, BRAINBox, a developer of brain injury diagnosis and prognosis systems, completed its Series B financing round led by Genoa Ventures. The funds will be used for obtaining regulatory approval for related products, commercializing the BRAINBox TBI concussion diagnosis/prognosis test, and conducting a clinical study on pediatric patients.Minimally Invasive and Non-Invasive Energy Medical Solutions Provider, Weimai Medical, Completes New Round of FinancingOn October 27, Vymed Medical, a provider of comprehensive solutions for minimally invasive and non-invasive energy medicine, received strategic investment from Botanee Group. The investor is Botanee Group. This round of financing will further strengthen the technical barriers and improve the layout in the field of medical energy.Population Health Management Solution Provider HealthEC Secures New Round of FinancingOn October 25, HealthEC, a population health management solutions provider, announced that it had secured additional funding from investors including HLM Venture Partners and Labcorp Venture Fund. The company plans to use the funds to pursue new value-based care opportunities in healthcare while expanding its behavioral health management platform.02 Digital Health Industry Dynamics
SpliceBio Collaborates with Spark Therapeutics, a Subsidiary of RocheRecently, SpliceBio announced an exclusive collaboration and licensing agreement with Spark Therapeutics to develop a gene therapy using SpliceBio's proprietary protein splicing platform for the treatment of an undisclosed inherited retinal disease. SpliceBio is eligible to receive up to $216 million in total payments.Johnson & Johnson Partners with Chang Medical to Advance Stroke Diagnosis and TreatmentRecently, Johnson & Johnson Medical Technology, one of the world's leading medical technology companies, and its subsidiary Johnson (Shanghai) Medical Devices Co., Ltd., formally signed a strategic cooperation agreement with Changyi Innovation, a domestic medical innovation enterprise in China. Guided by clinical needs, the two parties will collaborate in market expansion, technological advancement, and innovative cooperation to promote high-quality development in stroke diagnosis and treatment, enabling Chinese patients to benefit from local medical innovation achievements.Beckman Coulter Collaborates with 10x GenomicsRecently, Beckman CoulterLife SciencesEntered into a collaboration agreement with 10x Genomics to jointly develop an automated single-cell testing workflow. As part of the agreement, 10x Genomics will develop and validate a dedicated Chromium single-cell reagent kit for use with Beckman Coulter's Biomek i7 automated liquid handler.03 Overview of Global Digital Health M&ALilly Acquires Verve's Four PipelinesOn October 31, Beam Therapeutics, a biotechnology company, announced that Eli Lilly has agreed to acquire certain rights from the amended collaboration and license agreement signed between Beam and Verve Therapeutics. These rights include Beam’s option to co-develop and co-commercialize Verve’s base editing programs for cardiovascular diseases, which include programs targeting PCSK9, ANGPTL3, and an undisclosed liver-mediated cardiovascular target.IZI Medical Products Acquires AprioMedOn October 25, UK-based Halma Group acquired AprioMed for its healthcare division, IZI Medical Products. Located in Uppsala, Sweden, AprioMed specializes in the design, manufacture, and sale of medical devices used for bone biopsies. Its products assist in diagnosing a range of diseases, primarily cancer. AprioMed’s various biopsy needle devices are suitable for minimally invasive surgeries, filling a product gap for IZI in the diagnosis and treatment of cancer.Artery Network/Arterial Orange Industry Think Tank/China Renaissance/China Great Health/Rock Health/Mobile Health News/Fierce Health, etc.
Compiled by: Zhang Qiankun
